当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Drug development for noncastrate prostate cancer in a changed therapeutic landscape
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2017-11-08 , DOI: 10.1038/nrclinonc.2017.177 Min Yuen Teo,Matthew J. O'Shaughnessy,Sean M. McBride,Herbert A. Vargas,Howard I. Scher
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2017-11-08 , DOI: 10.1038/nrclinonc.2017.177 Min Yuen Teo,Matthew J. O'Shaughnessy,Sean M. McBride,Herbert A. Vargas,Howard I. Scher
Drug development for noncastrate prostate cancer in a changed therapeutic landscape
中文翻译:
治疗领域不断变化的非cast割型前列腺癌药物开发
治疗领域不断变化的非cast割型前列腺癌药物开发
更新日期:2017-11-08
Drug development for noncastrate prostate cancer in a changed therapeutic landscape, Published online: 08 November 2017; doi:10.1038/nrclinonc.2017.177
中文翻译:
治疗领域不断变化的非cast割型前列腺癌药物开发
治疗领域不断变化的非cast割型前列腺癌药物开发
在线治疗方面,针对不断变化的治疗前景的非cast割型前列腺癌的药物开发,在线发表:2017年11月8日;doi:10.1038 / nrclinonc.2017.177